Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.

Chandler JM, Ye W, Mi X, Doty EG, Johnston JA
J Alzheimers Dis. 2024; 100(2):563-578. PMID: 38875031. Abstract